Table 2.
Redeemed cardioprotective medication from 2001 to 2009 by screening group
| Year | Glucose-lowering medicationa | Lipid-lowering medicationa | Anti-hypertensive medicationa | Totalb | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No-screening group | Screening group | No-screening group | Screening group | No-screening group | Screening group | |||||
| Clinically diagnosed |
Screen- detected |
Clinically diagnosed |
Screen- detected |
Clinically diagnosed | Screen- detected | |||||
| 2001 | 4928 (49.9) | 334 (31.4) | 31 (20.8) | 1518 (15.4) | 141 (13.2) | 26 (17.5) | 5396 (54.6) | 543 (51.0) | 77 (51.7) | 11,097 |
| 2002 | 10,028 (48.2) | 641 (25.0) | 106 (25.9) | 4679 (22.5) | 454 (17.7) | 132 (32.2) | 11,879 (57.1) | 1289 (50.3) | 250 (61.0) | 23,777 |
| 2003 | 16,288 (49.2) | 1050 (25.8) | 240 (34.7) | 10,703 (32.3) | 1098 (27.0) | 330 (47.8) | 19,823 (59.9) | 2183 (53.7) | 459 (66.4) | 37,866 |
| 2004 | 23,401 (50.8) | 1461 (28.9) | 373 (39.4) | 18,936 (41.1) | 1812 (35.8) | 585 (61.8) | 29,043 (63.0) | 2913 (57.5) | 664 (70.2) | 52,092 |
| 2005 | 30,458 (52.5) | 1900 (31.0) | 464 (43.4) | 27,176 (46.9) | 2539 (41.4) | 712 (67.4) | 38,124 (65.8) | 3707 (60.4) | 787 (74.5) | 65,180 |
| 2006 | 38,453 (54.8) | 2412 (31.2) | 583 (47.1) | 37,091 (52.9) | 3536 (45.7) | 920 (74.3) | 47,938 (68.3) | 4854 (62.8) | 948 (76.5) | 79,137 |
| 2007 | 47,162 (56.5) | 2986 (32.9) | 663 (52.7) | 48,218 (57.7) | 4689 (51.7) | 974 (77.4) | 58,837 (70.4) | 5967 (65.8) | 1003 (79.9) | 93,851 |
| 2008 | 57,087 (58.0) | 3618 (34.3) | 737 (58.5) | 60,981 (62.0) | 5895 (55.9) | 1018 (80.8) | 71,373 (72.5) | 7213 (68.4) | 1035 (82.1) | 110,198 |
| 2009 | 67,071 (59.2) | 4292 (36.6) | 764 (60.9) | 71,654 (63.3) | 6763 (57.7) | 1016 (81.0) | 83,834 (74.0) | 8273 (70.6) | 1048 (83.6) | 126,225 |
Parentheses show the proportion (%) of individuals in each screening group who redeemed a particular class of cardio-protective medication in each year
aAnatomical Therapeutic Chemical (ATC) codes: glucose-lowering medication (A*); lipid-lowering medication (C10*); anti-hypertensive medication (CO7*, CO8*, C09*)
bBased on all individuals alive on 31 December of the year in question who had previously been diagnosed with diabetes